drugset / Trial / NCT00952133

Efficacy of IV Palo With IV Dexamethasone vs IV Palo for Prevention of Immediate & Delayed PONV

NCT00952133

Phase 4 Completed 118 enrolled NYU Langone Health Eisai Inc. · collab
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to determine if subjects who receive Palonosetron plus Dexamethasone have less post-operative nausea and vomiting (PONV) than those who receive Palonosetron alone.

Timeline

Start
2009-07
Primary completion
2010-07
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 8 mg Intravenous
Comparator Palonosetron Other / unclassified 0.075 mg Intravenous

Indications

No indication recorded.